1. Y. P. Juang, T. Cernak* Invasive Species Management Through the Lens of Chemistry. Parks Stewardship Forum, 2025.05; 41: 134-141.

2. Y. P. Juang, Y. Huang, S. Linder, M. Keene, N. Sheldon, J. Burger, T. Cernak* Metabolomic Profiles of Limulus polyphemus Eggs. ChemRxiv. 2025; doi:10.26434/chemrxiv-2025-hsq0b

3. J. L. Douthwaite, D. Houde, E. Pardo, M. Moran, J. Baird, Q. Zhao, S. R. Meyer, B. Mahjour, J. Larrow, Y. P. Juang, C. Han, B. Kelley, D. Dunstan, K. Billings, M. Mader, A. Taylor, J. Z. Sexton, A. Boezio, T. Cernak* Nanoscale direct-to-biology optimization of Cdk2 inhibitors. ChemRxiv. 2025; doi:10.26434/chemrxiv-2025-4fr3l.

4. A. M. Glendening, C. Stephens, V. S. Vuruputoor, T. Chaganti, M. N. Nyles, D. L. Stern, M. Abdelalim, Y. P. Juang, S. A. Hogenhout, T. C. Mathers, N. Pauloski, T. A. Cernak*, J. L. Wegrzyn*, K. C. Fetter* Chromosome scale genomes of two invasive Adelges species enable virtual screening for selective adelgicides. bioRxiv 2024.11.21.624573; doi: 10.1101/2024.11.21.624573.

5. T. Chaganti, C. Y. Tsai, Y. P. Juang, M. Abdelalim, T. Cernak*: Medicinal Chemistry Gone Wild., J. Med. Chem., 2024.05; 67: 6899-6905.

6. Y. P. Juang, J. Y. Tsai, W. L. Gu, H. C. Hsu, C. L. Lin, C. C. Wu*, P. H. Liang*: Discovery of 5‑Hydroxy-1,4-naphthoquinone (Juglone) Derivatives as Dual Effective Agents Targeting Platelet-Cancer Interplay through Protein Disulfide Isomerase Inhibition., J. Med. Chem., 2024.02; 67: 3626-3642.

7. O. Chou, Y. P. Juang, T. L. Chao, S. F. Tsai, P. F. Chiu, C. T. Chiou, K. C. Tsai, S. Y. Chang, P. H. Liang*, C. H. Wong*: Isolation of anti-SARS-CoV-2 natural products extracted from Mentha canadensis and the semi-synthesis of antiviral derivatives., J. Nat. Prod., 2023.06; 86: 1428-1436.

8. Y. P. Juang, Y. T. Chou, R. X. Lin, H. H. Ma, T. L. Chao, J. T. Jan, S. Y. Chang, P. H. Liang*: Design, synthesis and biological evaluations of niclosamide analogues against SARS-CoV-2., Eur. J. Med. Chem., 2022.03; 235: 114295.

9. C. K. Chang, P. F. Chiu, H. Y. Yang, Y. P. Juang, Y. H. Lai, T. S. Lin, L. C. Hsu, C. H. Yu, P. H. Liang*: Targeting colorectal cancer with conjugates of a glucose transporter inhibitor and 5-fluorouracil., J. Med. Chem., 2021.04; 64: 4450-4461.

10. J. T. Jan, T. J. Cheng, Y. P. Juang, H. H. Ma, Y. T. Wu, W. B. Yang, C. W. Cheng, X. Chen, T. H. Chou, J. J. Shie, W. C. Cheng, R. J. Chein, S. S. Mao, P. H. Liang*, C. Ma*, S. C. Hung*, C. H. Wong*: Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection., Proc. Natl. Acad. Sci. U.S.A., 2021.01; 118: e2021579118.

11. Y. P. Juang, P. H. Liang*: Biological and Pharmacological Effects of Synthetic Saponins., Molecules, 2020.10, 25, 4974.

12. Y. P. Juang, Y. Y. Lin, S. H. Chan, C. K. Chang, J. J. Shie, Y. S. Y. Hsieh, J. H. Guh, P. H. Liang*: Synthesis, distribution analysis and mechanism studies of N-acyl glucosamine-bearing oleanolic saponins., Bioorg. Chem., 2020.04; 99: 103835.

13. T. S. Lin, C. H. Hsieh, C. Kuo, Y. P. Juang, Y. S. Y. Hsieh, H. Chiang, S. C. Hong, C. C. Jiang, P. H. Liang*: Sulfation Pattern of Chondroitin Sulfate in Human Osteoarthritis Cartilages Reveals a Lower Level of Chondroitin-4-Sulfate., Carbohydr. Polym., 2020.02, 229: 115496.

14. Y. Y. Lin, S. H. Chan, Y. P. Juang, H.M. Hsiao, J. H. Guh, P. H. Liang*: Design, synthesis and cytotoxic activity of N-modified oleanolic saponins bearing a glucosamine., Eur. J. Med. Chem., 2018.01, 143: 1942-1958.